Active	Status	Sponsor type	Region	Phase	Filter
3 Active 2 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Yin, Xiaoyu
ENREACH-PDAC-01, NCT05149326: KN046 in Subjects With Advanced Pancreatic Ductal Adenocarcinoma.	Active, not recruiting	3	408	RoW	KN046, placebo	Jiangsu Alphamab Biopharmaceuticals Co., Ltd	Advanced Pancreatic Ductal Adenocarcinoma	04/24	08/24
CIBI343A101, NCT05458219: A First-in-human Study of IBI343 in Subjects with Locally Advanced Unresectable or Metastatic Solid Tumors	Recruiting	1	470	US, RoW	IBI343	Innovent Biologics (Suzhou) Co. Ltd., Innovent Biologics, Inc., TigerMed	Locally Advanced Unresectable or Metastatic Solid Tumors	12/25	12/25
Song, Rongfeng
CIBI343A101, NCT05458219: A First-in-human Study of IBI343 in Subjects with Locally Advanced Unresectable or Metastatic Solid Tumors	Recruiting	1	470	US, RoW	IBI343	Innovent Biologics (Suzhou) Co. Ltd., Innovent Biologics, Inc., TigerMed	Locally Advanced Unresectable or Metastatic Solid Tumors	12/25	12/25